Ali Behbahani - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 261,024 shares made by Samarth Kulkarni , a net sale of 25,642 shares made by James R. Kasinger , and a net sale of 6,801 shares made by .

In summary, during the past 3 months, insiders sold 89,481 shares of CRISPR Therapeutics AG (CRSP) in total and bought 7,000 shares, with a net sale of 82,481 shares. During the past 18 months, 302,950 shares of CRISPR Therapeutics AG (CRSP) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 295,950 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 18,261 shares made by Alicia J. Hager , a net sale of 28,845 shares made by Paul J Hastings , and a net sale of 12,646 shares made by David Shook .

In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 84,937 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,915,063 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 158,756 shares made by Adrian Rawcliffe , a net sale of 60,150 shares made by Elliot Norry , and a net sale of 57,944 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 371,522 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 371,522 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 96,058 shares made by Jennifer L Good , a net sale of 104,000 shares made by Thomas Sciascia , and a net sale of 81,313 shares made by Farrell Simon .

In summary, during the past 3 months, insiders sold 89,207 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 89,207 shares. During the past 18 months, 290,276 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 290,276 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .

In summary, during the past 3 months, insiders sold 5,784,292 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 5,784,292 shares. During the past 18 months, 6,005,892 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,892 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 91,634 shares made by Joseph P Hagan , a net sale of 49,272 shares made by Crispina Calsada , and a net sale of 49,103 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 69,610 shares, with a net purchase of 69,610 shares. During the past 18 months, 271,454 shares of Regulus Therapeutics Inc (RGLS) were sold and 73,610 shares were bought by its insiders, resulting in a net sale of 197,844 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 69,375 shares made by Jolanda Howe , a net sale of 38,032 shares made by Peter Radovich , and a net sale of 101,929 shares made by Christopher Peetz .

In summary, during the past 3 months, insiders sold 162,822 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 6,364 shares, with a net sale of 156,458 shares. During the past 18 months, 256,352 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 13,619 shares were bought by its insiders, resulting in a net sale of 242,733 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Marker Therapeutics Inc (MRKR). Other recent insider transactions involving Marker Therapeutics Inc (MRKR) include a net purchase of 554,250 shares made by New Enterprise Associates 16, L.p. , and a net purchase of 11,085 shares made by Steve Elms .

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 565,335 shares were bought by its insiders, resulting in a net purchase of 565,335 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 690,513 shares made by Paula Ragan , a net sale of 179,382 shares made by Mary Dibiase , and a net sale of 616,284 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 0 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,707,983 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 35,050 shares were bought by its insiders, resulting in a net sale of 1,672,933 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Savara Inc (SVRA). Other recent insider transactions involving Savara Inc (SVRA) include a net purchase of 250,000 shares made by David A Ramsay , a net sale of 138,702 shares made by Matthew Pauls , and a net sale of 35,000 shares made by David L Lowrance .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc (SVRA) in total and bought 150,000 shares, with a net purchase of 150,000 shares. During the past 18 months, 275,545 shares of Savara Inc (SVRA) were sold and 270,000 shares were bought by its insiders, resulting in a net sale of 5,545 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net purchase of 8,500 shares made by Joseph P Slattery , a net sale of 3,975 shares made by Paul Verrastro , and a net purchase of 30,000 shares made by Kevin Hykes .

In summary, during the past 3 months, insiders sold 0 shares of CVRx Inc (CVRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,700 shares of CVRx Inc (CVRX) were sold and 38,500 shares were bought by its insiders, resulting in a net purchase of 30,800 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Minerva Surgical Inc (UTRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Surgical Inc (UTRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Minerva Surgical Inc (UTRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 198,867 shares made by Mikan George Lawrence Iii , a net sale of 18,858 shares made by Jay Matushak , and a net sale of 5,783 shares made by Jeffrey J Scherman .

In summary, during the past 3 months, insiders sold 120,194 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 120,194 shares. During the past 18 months, 243,283 shares of NeueHealth Inc (NEUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,283 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 373,662 shares made by Christopher Heery , a net sale of 88,479 shares made by Kavita Patel , and a net sale of 109,308 shares made by Michelle Gilson .

In summary, during the past 3 months, insiders sold 54,455 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 54,455 shares. During the past 18 months, 1,816,068 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,816,068 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , a net sale of 2,817 shares made by Edmund Dunn , and a net purchase of 10,000 shares made by Chandra P. Leo .

In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 1,850,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 11,016 shares made by Vineet Agarwal , a net sale of 2,124 shares made by David L. Lucchino , and a net purchase of 17,857 shares made by Florence Anthony A. Jr. .

In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,140 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 165,430 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.